The Impact of the COVID-19 Pandemic and Lockdowns on Self-Poisoning and Suicide in Sri Lanka: An Interrupted Time Series Analysis.
COVID-19
Sri Lanka
global mental health
low- and middle-income country
pandemic
self-harm
suicide
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
19 01 2023
19 01 2023
Historique:
received:
19
12
2022
revised:
11
01
2023
accepted:
16
01
2023
entrez:
11
2
2023
pubmed:
12
2
2023
medline:
15
2
2023
Statut:
epublish
Résumé
Evidence from high-income countries suggests that the impact of COVID-19 on suicide and self-harm has been limited, but evidence from low- and middle-income countries is lacking. Using data from a hospital-based self-poisoning register (January 2019-December 2021) and data from national records (2016-2021) of suicide in Sri Lanka, we aimed to assess the impact of the pandemic on both self-poisoning and suicide. We examined changes in admissions for self-poisoning and suicide using interrupted time series (ITS) analysis. For the self-poisoning hospital admission ITS models, we defined the lockdown periods as follows: (i) pre-lockdown: 01/01/2019-19/03/2020; (ii) first lockdown: 20/03/2020-27/06/2020; (iii) post-first lockdown: 28/06/2020-11/05/2021; (iv) second lockdown: 12/05/2021-21/06/2021; and (v) post-second lockdown: 22/06/2021-31/12/2021. For suicide, we defined the intervention according to the pandemic period. We found that during lockdown periods, there was a reduction in hospital admissions for self-poisoning, with evidence that admission following self-poisoning remained lower during the pandemic than would be expected based on pre-pandemic trends. In contrast, there was no evidence that the rate of suicide in the pandemic period differed from that which would be expected. As the long-term socioeconomic impacts of the pandemic are realised, it will be important to track rates of self-harm and suicide in LMICs to inform prevention.
Identifiants
pubmed: 36767200
pii: ijerph20031833
doi: 10.3390/ijerph20031833
pmc: PMC9914278
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Wellcome Trust
ID : 204813
Pays : United Kingdom
Références
Lancet Psychiatry. 2021 Oct;8(10):892-900
pubmed: 34332697
Depress Anxiety. 2021 May 5;:
pubmed: 33949747
Int J Epidemiol. 2017 Feb 1;46(1):348-355
pubmed: 27283160
EClinicalMedicine. 2022 Aug 02;51:101573
pubmed: 35935344
PLoS One. 2013;8(1):e51333
pubmed: 23341881
Lancet Glob Health. 2017 Jul;5(7):e651-e652
pubmed: 28619217
Asian J Psychiatr. 2016 Feb;19:79-84
pubmed: 26957344
Am J Prev Med. 2017 Apr;52(4):469-475
pubmed: 27856114
BMC Psychiatry. 2022 Apr 29;22(1):304
pubmed: 35488326
BMC Public Health. 2014 Aug 13;14:839
pubmed: 25118074
Asian J Psychiatr. 2022 Mar;69:102983
pubmed: 34974320
Lancet Psychiatry. 2021 Jul;8(7):579-588
pubmed: 33862016
Int J Soc Psychiatry. 2015 Feb;61(1):73-81
pubmed: 24903684
J Affect Disord. 2008 Jul;109(1-2):139-48
pubmed: 18221789
Soc Psychiatry Psychiatr Epidemiol. 2008 Apr;43(4):280-5
pubmed: 18253684
Prev Med. 2021 Nov;152(Pt 1):106547
pubmed: 34538371
World Psychiatry. 2020 Jun;19(2):250-251
pubmed: 32394579
World J Psychiatry. 2015 Jun 22;5(2):243-54
pubmed: 26110126
Br J Psychiatry. 2022 Oct;221(4):603-612
pubmed: 35816104
Psychol Health Med. 2022 Sep 4;:1-9
pubmed: 36062630
BMC Public Health. 2016 Feb 03;16:115
pubmed: 26847554
Int J Epidemiol. 2007 Dec;36(6):1235-42
pubmed: 17726039
Ceylon Med J. 2012 Dec;57(4):152-8
pubmed: 23292057
Ceylon Med J. 2021 Jun 30;66(2):87-95
pubmed: 35569005
Bull World Health Organ. 2008 Sep;86(9):726-32
pubmed: 18797649